Search Results - "Barinoff, J."

Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial by Denkert, C., Loibl, S., Müller, B.M., Eidtmann, H., Schmitt, W.D., Eiermann, W., Gerber, B., Tesch, H., Hilfrich, J., Huober, J., Fehm, T., Barinoff, J., Jackisch, C., Prinzler, J., Rüdiger, T., Erbstößer, E., Blohmer, J.U., Budczies, J., Mehta, K.M., von Minckwitz, G.

“…The proliferation marker Ki67 has been suggested as a promising cancer biomarker. As Ki67 needs an exact quantification, this marker is a prototype of a new…”
Get full text

Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer by Michiels, S., Pugliano, L., Marguet, S., Grun, D., Barinoff, J., Cameron, D., Cobleigh, M., Di Leo, A., Johnston, S., Gasparini, G., Kaufman, B., Marty, M., Nekljudova, V., Paluch-Shimon, S., Penault-Llorca, F., Slamon, D., Vogel, C., von Minckwitz, G., Buyse, M., Piccart, M.

“…The gold standard end point in randomized clinical trials in metastatic breast cancer (MBC) is overall survival (OS). Although therapeutics have been approved…”
Get full text

Aktuelle Studien und experimentelle Ansätze in der Therapie von Karzinomen der Vulva- und Vagina by Barinoff, J.

“…Zusammenfassung Hintergrund Es gibt wenige prospektiv durchgeführte und bis dato abgeschlossene Studien zum Thema Therapie eines Vulva- oder Vaginalkarzinoms…”
Get full text

Establishment of a Mucin Secreting Cell Line Cx-03 from an Uterine Carcino Sarcoma by Bücker, R., Schaefer, C., Gruber, A. D., Hoppe, J., Lazzerini, L., Barinoff, J., Sehouli, J., Cichon, Günter

“…Purpose The identification of novel cell lines which combine the most important properties of mucosal membranes in terms of drug absorption, transmembrane…”
Get full text

OC17.05: New sonographic and hysteroscopic combined classification for surgical repair of isthmoceles in an outpatient setting to ensure maximum safety in minimal invasive surgery by Dueckelmann, A.M., Barinoff, J., Gubbini, G., Sehouli, J., Boschetti Grützmacher, E.

Get full text

Cerebral metastases in metastatic breast cancer: disease-specific risk factors and survival by Heitz, F., Rochon, J., Harter, P., Lueck, H.-J., Fisseler-Eckhoff, A., Barinoff, J., Traut, A., Lorenz-Salehi, F., du Bois, A.

“…Survival of patients suffering from cerebral metastases (CM) is limited. Identification of patients with a high risk for CM is warranted to adjust follow-up…”
Get full text

Diagnosis, Therapy and Follow-up Care of Vulvar Cancer and its Precursors. Guideline of the DGGG and DKG (S2k-Level, AWMF Registry Number 015/059, November 2015 by Schnürch, H G, Ackermann, S, Alt, C D, Barinoff, J, Böing, C, Dannecker, C, Gieseking, F, Günthert, A, Hantschmann, P, Horn, L C, Kürzl, R, Mallmann, P, Marnitz, S, Mehlhorn, G, Hack, C C, Koch, M C, Torsten, U, Weikel, W, Wölber, L, Hampl, M

“…This is an official guideline, published and coordinated by the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO, Study Group for Gynecologic Oncology) of the…”
Get full text

Clinicopathological differences between breast cancer in patients with primary metastatic disease and those without: A multicentre study by Barinoff, J, Hils, R, Bender, A, Groß, J, Kurz, C, Tauchert, S, Mann, E, Schwidde, I, Ipsen, B, Sawitzki, K, Heitz, F, Harter, P, Traut, A, du Bois, A

“…Abstract Objective Approximately 6% of breast cancer (BC) patients present with primary metastatic disease (pmBC) at first diagnosis. The clinicopathological…”
Get full text

Prognostic Impact of Additional Extended Surgical Procedures in Advanced-Stage Primary Ovarian Cancer by Kommoss, S., Rochon, J., Harter, P., Heitz, F., Grabowski, J. P., Ewald-Riegler, N., Haberstroh, M., Neunhoeffer, T., Barinoff, J., Gomez, R., Traut, A., du Bois, A.

“…Background Treatment of advanced-stage ovarian carcinoma includes radical cytoreductive surgery, which aims at removing all visible tumor tissue followed by…”
Get full text

Prognostic Factors for Local, Loco-regional and Systemic Recurrence in Early-stage Breast Cancer by Kümmel, A, Kümmel, S, Barinoff, J, Heitz, F, Holtschmidt, J, Weikel, W, Lorenz-Salehi, F, du Bois, A, Harter, P, Traut, A, Blohmer, J U, Ataseven, B

“…The risk of recurrence in breast cancer depends on factors such as treatment but also on the intrinsic subtype. We analyzed the risk factors for local,…”
Get full text

11 Everolimus (Rad001) as Treatment in Breast Cancer Patients with Bone Metastases Only – First Results of the Multi-centre, Placebo-controlled, Randomized Discontinuation Phase II RADAR Study by Harbeck, N, Maass, N, Mundhenke, C, Lerchenmüller, C, Barinoff, J, Etti, J, Aktas, B, Nekljudova, V, von Minckwitz, G, Loibl, S

Get full text

Suspekte Endometriumhyperplasie by Pfeiffer, J., Heinrichs, C., Barinoff, J. M.

Get full text

Chemotherapy for 70-Year-Old Women with Breast Cancer in Germany: A Survey by the German Breast Group by Barinoff, J, Traut, A, Bauerschlag, D, Bischoff, J, Herr, D, Lübbe, K, Lück, H-J, Maass, N, Mundhenke, C, Schmidt, M, Schwedler, K, Thill, M, Steffen, J, Loibl, S, von Minckwitz, G

“…Around half of all women in Germany with breast cancer are older than 65 and approximately one third of them is older than 70 years of age. In theory, the…”
Get full text

Erratum zu: Suspekte Endometriumhyperplasie by Pfeiffer, J., Heinrichs, C., Barinoff, J. M., Thill, M.

Get full text

166P Breast cancer at the age of 90 and above by Barinoff, J., Ho, K.C.K., Schikschneit, J., St.hilaire, U., Brandt, K., Vornhecke, M.Y.

Get full text

Ichthyosis uteri (psoriasis uteri) : A very rare disorder by von Laffert, M, Elezkurtaj, S, Sehouli, J, Barinoff, J, Boschetti Grützmacher, E, Arsenic, R, Bläker, H

“…In ichthyosis uteri, the entire endometrium is replaced by squamous, sometimes even keratotic epithelium. The etiology is discussed controversially and not…”
Get full text

28P EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy by Leichsenring, J., Vladimirova, V., Solbach, C., Karn, T., Ataseven, B., Sinn, B., Barinoff, J., Mueller, V., Blohmer, J-U., Schem, C., Engels, K., Marmé, F., Fissler-Eckhoff, A., Fasching, P.A., Stickeler, E., van Mackelenbergh, M., Denkert, C., Stenzinger, A., Loibl, S., Gröschel, S.

Get full text

Abstract P2-08-15: Impact of OncotypeDX on treatment decision for early stage, hormone-receptor-positive breast cancer by Anastasiadou, L, Schneider, M, Barinoff, J, Khandan, F, Falk, S, Thill, M

“…Abstract BACKGROUND and OBJECTIVE The OncotypeDX multigene assay analyzes the individual biology of an invasive breast cancer by examining the activity of 16…”
Get full text

Abstract OT3-04-04: 21-gene recurrence score® in patients with primary metastatic ER+ HER2- breast cancer by Barinoff, J, Anastasiadou, L, Brandi, C, Junker-Stein, A, Silbermann, J, Langenfeld, M, Fortmann, C, Thill, M

“…Abstract Background and Purpose Results from the 21-gene Recurrence Score (RS) are prognostic and predictive for recurrence in early breast cancer independent…”
Get full text

Ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trial by Möbus, V., Jackisch, C., Lück, H.J., du Bois, A., Thomssen, C., Kuhn, W., Nitz, U., Schneeweiss, A., Huober, J., Harbeck, N., von Minckwitz, G., Runnebaum, I.B., Hinke, A., Konecny, G.E., Untch, M., Kurbacher, C.

“…Primary breast cancer (BC) patients with extensive axillary lymph-node involvement have a limited prognosis. The Arbeitsgemeinschaft fuer Gynaekologische…”
Get full text